Roche Pharmaceutical Development and Sales Overview

CER sales growth (%) Quarterly development 2021 vs. 2020 2022 vs. 2021 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Pharmaceuticals Division -9 4 5 14 6 0 -6 United States -14 0 0 8 2 1 -6 Europe -6 15 1 19 -1 -6 4 Japan -7 7 60 46 69 3 -27 International 0 4 2 9 0 4 -3 Diagnostics Division 55 48 18 8 24 0 -4 Roche Group 3 14 8 12 11 0 -6 CER-Constant Exchange Rates Roche 150

View entire presentation